Delivery Order SPE2DB22D3009-SPE2DB25FBE07
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, valued at $3,574.80 with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,362.20 on September 4, 2025, for the supply of BOTOX Cosmetic 100-unit vials, with an ultimate completion date of September 25, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $12,045.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. The contract is a firm fixed price delivery order with a completion date of August 27, 2025, and was awarded on August 6, 2025 without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $4,021.65 and an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $4,306.80 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among eligible vendors. This delivery...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBE07Delivery Order
The Defense Logistics Agency awarded a $6,702.75 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for Botox Cosmetic 100 Unit Vials with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. Through its DLA contract vehicle, the company serves multiple government customers including the Defense Health Agency and U.S. Coast Guard. The company's track record includes successful delivery of diverse pharmaceutical products across multiple therapeutic domains under competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/26/25 |